Skip to content
OpenCapital
Get started

Agilon Health AGL Total Cash, Cash Equivalents, and Restricted Cash (Inclusive)

Total Cash, Cash Equivalents, and Restricted Cash (Inclusive) at other companies

Inter Parfums logo
Inter ParfumsIPAR
$158.09M+26.0%
MarketAxess logo
MarketAxessMKTX
$548.24M-14.9%
SM Energy logo
SM EnergySM
$449M—
Celcuity logo
CelcuityCELC
$145.19M+781%
BGC Group, Inc. logo
BGC Group, Inc.BGC
$803.1M-18.5%
UMH
UMH PropertiesUMH
$45.97M-1.1%

Other financials

Income statement

See full
Revenue$1.4B-7.3%
Operating income$4.0M+118%
Net income$48.9M+304%
EPS (diluted)$2.94+303%

Balance sheet

See full
Cash & equivalents$211.6M+52.6%
Total debt$33.4M-20.5%
Total equity$181.4M-63.7%
Total assets$1.5B-22.1%

Cash flow

See full
Operating cash flow$23.7M+174%
CapEx$3.1M-19.4%
Free cash flow$20.6M+158%

Valuation

See full
Market cap$1.78B-92.6%
Enterprise value$1.61B-103%
P/S0.3×-3.8×

Profitability

See full
Operating margin-7.5%+6.5pp
Net margin-6.1%+6.3pp
FCF margin-1.1%—

Returns & leverage

See full
Return on equity-104%-291pp
Debt / equity0.2×+0.1×
Current ratio1×-0.2×

Where this comes from

Reported directly by Agilon Health in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Agilon Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilon Health's total cash, cash equivalents, and restricted cash (inclusive).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agilon Health's total cash, cash equivalents, and restricted cash (inclusive)?
Agilon Health (AGL) reported total cash, cash equivalents, and restricted cash (inclusive) of $211.57M in Q1 2026.
How has Agilon Health's total cash, cash equivalents, and restricted cash (inclusive) changed year-over-year?
Agilon Health's total cash, cash equivalents, and restricted cash (inclusive) increased by 52.6% year-over-year, from $138.62M to $211.57M.
What is the long-term trend for Agilon Health's total cash, cash equivalents, and restricted cash (inclusive)?
Over 3 years (2022 to 2025), Agilon Health's total cash, cash equivalents, and restricted cash (inclusive) has grown at a 76.2% compound annual growth rate (CAGR), from $31.77M to $173.71M.